We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Arana Therap. | LSE:AAHX | London | Ordinary Share | AU000000AAH8 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:0544S
Arana Therapeutics Limited
10 April 2008
For Immediate Release 10 April 2008
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer advises that on 10 April 2008 Lim Sen Yap has advised the
Australian Securities Exchange (www.asx.com.au) (ASX) that himself and his
associates (as defined under the Corporations Act 2001 (Australia)) held a total
of 27,378,853 ordinary shares in the Company (11.65% of the issued share capital
of the Company) as at 4 April 2008, compared with 24,984,089 ordinary shares of
the Company (10.63% of the issued share capital of the Company) advised to the
ASX on 26 February 2008. A copy of the notice filed by Lim Sen Yap today is
attached.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGCGDSUDBGGIG
1 Year Arana Therap. Chart |
1 Month Arana Therap. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
